魏丹;朱岩岩;杨玉峰;李建波;李国平;

• 1:濮阳市安阳地区医院
• 2:新乡医学院第一附属医院

摘要(Abstract)：

目的分析脑出血患者肝细胞生长因子(HGF)、神经生长因子(NGF)水平与神经功能缺损的相关性。方法选取濮阳市安阳地区医院2018-01—2020-01收治的237例脑出血患者为研究对象,均于入院时检测HGF及NGF水平,于发病72 h时评估神经功能缺损程度,分析HGF和NGF水平与患者神经功能缺损的相关性。结果 237例脑出血患者中神经功能缺损轻中度90.72%,重度9.28%;重度神经功能缺损患者入院时血清HGF及NGF水平均高于轻中度神经功能缺损患者(P<0.05);单项Logistic回归分析后建立多元Logistic回归模型,结果显示脑出血患者入院时血清HGF及NGF水平过表达是推动患者神经功能缺损程度加重的影响因素(OR>1,P<0.05);绘制受试者工作曲线(ROC)发现,脑出血患者入院时血清HGF、NGF水平单项预测及联合预测神经功能缺损重度风险的曲线下面积(AUC)均>0.80,有一定预测性能。结论脑出血患者血清HGF、NGF水平与神经功能缺损程度密切相关,入院时血清HGF、NGF高水平可能提示患者神经功能缺损程度严重,可将入院时血清HGF、NGF水平作为脑出血患者神经功能缺损程度的有效预测因子。

关键词(KeyWords)： 脑出血;肝细胞生长因子;神经生长因子;神经功能缺损;相关性

Abstract:

Keywords:

基金项目(Foundation): 河南省医学科技攻关计划（联合共建）项目（编号：LHGJ20190439）

作者(Authors): 魏丹;朱岩岩;杨玉峰;李建波;李国平;

参考文献(References)：

• [1]YOU S,WANG X,LINDLEY B I,et al.Early Cognitive Impairment after Intracerebral Hemorrhage in the INTER-ACT1 Study[J].Cerebrovasc Dis,2017,44(5/6):320-324.
• [2]REYES R,VISWANATHAN M,AIYAGARI V.An update on neurocritical care for intracerebral hemorrhage[J].Expert Rev Neurother,2019,19(6):557-578.
• [3]HUGE V.Critical care management of intracerebral hemorrhage[J].Med Klin Intensivmed Notfmed,2018,113(3):164-173.
• [4]CORDONNIER C,DEMCHUK A,ZIAI W,et al.Intracerebral haemorrhage:current approaches to acute management[J].Lancet,2018,392(10154):1257-1268.
• [5]LI X,CAO R,LU H,et al.Cerebral hemorrhage therapy by targeting VEGF and HGF in a preclinical trial in rats[J].Mol Med Rep,2017,15(5):3093-3098.
• [6]JABLOCHKOVA A,B?CKRYD E,KOSEK E,et al.Unaltered low nerve growth factor and high brain-derived neurotrophic factor levels in plasma from patients with fibromyalgia after a 15-week progressive resistance exercise[J].J Rehabil Med,2019,51(10):779-787.
• [7]周建波，周璐芬，杨小华.鼠神经生长因子联合丹红注射液治疗急性脑梗死认知功能障碍临床分析[J].中国实用神经疾病杂志，2020,23(6):506-509.
• [8]DUNNING K.National Institutes of Health Stroke Scale[J].Encyclopedia of Clinical Neuropsychology,2011,9(1):1714-1715.
• [9]FALLENIUS M,SKRIFVARS M B,REINIKAINEN M,et al.Spontaneous Intracerebral Hemorrhage[J].Stroke,2019,50(9):2336-2343.
• [10]ZIAI W C,CARHUAPOMA J R.Intracerebral Hemorrhage[J].Continuum (Minneap Minn),2018,24(6):1603-1622.
• [11]MORGENSTERN L B.Prognosis after intracerebral hemorrhage is uncertain,so why not do everything[J].Ann Neurol,2019,86(4):493-494.
• [12]SENADIM S,CABALAR M,YAYLA V,et al.The evaluation of the relationship between risk factors and prognosis in intracerebral hemorrhage patients[J].Ideggyogy Sz,2017,70(1/2):33-41.
• [13]SCHOEMAKER R,NAYAK S,HARNISCH L O,et al.Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage[J].J Pharmacokinet Pharmacodyn,2019,46(5):473-484.
• [14]RYNKOWSKI C B,MANOEL A L D O,REIS M M D,et al.Early Transcranial Doppler Evaluation of Cerebral Autoregulation Independently Predicts Functional Outcome After Aneurysmal Subarachnoid Hemorrhage[J].Neurocrit Care,2019,31(2):253-262.
• [15]MIYAHARA M,NODA R,YAMAGUCHI S,et al.New Prediction Score for Hematoma Expansion and Neurological Deterioration after Spontaneous Intracerebral Hemorrhage:A Hospital-Based Retrospective Cohort Study[J].J Stroke Cerebrovasc Dis,2018,27(9):2543-2550.
• [16]LIU J,YANG H,YU B.The correlation between blood calcium level,hematoma volume,stroke severity and prognosis in patients with acute cerebral hemorrhage[J].Eur Rev Med Pharmacol Sci,2016,20(19):4119-4123.
• [17]INOUE Y,MIYASHITA F,KOGA M,et al.Unclear-onset intracerebral hemorrhage:Clinical characteristics,hematoma features,and outcomes[J].Int J Stroke,2017,12(9):961-968.
• [18]ROCCO M L,SOLIGO M,MANNI L,et al.Nerve Growth Factor:Early Studies and Recent Clinical Trials[J].Curr Neuropharmacol,2018,16(10):1455-1465.
• [19]RUBERG F L,SIDDIQI O K.Hepatocyte Growth Factor and Cardiac Amyloidosis[J].JACC Cardio Oncol,2020,2(1):67-69.
• [20]HAN Z,WANG C P,CONG N,et al.Therapeutic value of nerve growth factor in promoting neural stem cell survival and differentiation and protecting against neuronal hearing loss[J].Mol Cell Biochem,2017,428(1/2):149-159.
• [21]SUN Y Z,XU B Q,ZHANG Q.Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage[J].Pak J Med Sci,2018,34(1):73-77.
• [22]GINCBERG G,SHOHAMI E,TREMBOVLER V,et al.Nerve growth factor plays a role in the neurotherapeutic effect of a CD45+pan-hematopoietic subpopulation derived from human umbilical cord blood in a traumatic brain injury model[J].Cytotherapy,2018,20(2):245-261.
• [23]AOKI M,WARITA H,KATO M,et al.Application of Hepatocyte Growth Factor for Amyotrophic Lateral Sclerosis[J].Brain Nerve,2019,71(11):1253-1260.
• [24]YAMANE K,MISAWA H,TAKIGAWA T,et al.Multipotent Neurotrophic Effects of Hepatocyte Growth Factor in Spinal Cord Injury[J].Int J Mol Sci,2019,20(23):6078.
• [25]ZHOU Z R,ZHAO Y H,SUN R,et al.Effects of Xingnaojing on serum high-sensitivity C-reactive protein and neuron-specific enolase in patients with acute cerebral hemorrhage:A protocol of systematic review and meta-analysis[J].Medicine (Baltimore),2020,99(45):e21379.
• [26]白新涛，韩亚，于亚亮.高血压脑出血患者心率变异性与早期神经功能恶化的相关性[J].中国实用神经疾病杂志，2020,23(16):1439-1443.
• [27]KOLE M J,WESSELL A P,UGILIWENEZA B,et al.Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction[J].Neurosurgery,2020,2:nyaa473.
• [28]YU J,ZHOU F,ZHANG Y.Comparision of early interventional rehabilitation training with delayed training on motor function recovery in patients with cerebral haemorrhage[J].J Pak Med Assoc,2020,70(9):71-77.